Tom Marvin - BikeRadar bikeradar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bikeradar.com Daily Mail and Mail on Sunday newspapers.
Register-Mail named 2nd best small daily in Illinois
The Register-Mail was named second best small daily newspaper in Illinois in one newspaper contest Friday and in another its Black Voices series was named best writing entry among all the state’s mid-sized newspapers.
The results of two contests were announced Friday. The Register-Mail had already reported its 16 awards in the Illinois Press Association contest when they were announced in April. Stories in the Black Voices of Galesburg series earned five of the 16 awards. Those awards were read aloud during the virtual conference Friday along with the two top awards, General Excellence (best overall newspaper based on two editions) and the sweepstakes award (which is given to the newspaper with the best finish across all categories. The Register-Mail earned second place in both.
play-icon
Video report by ITV News Political Correspondent Carl Dinnen
The UK is still on track to follow the roadmap out of lockdown despite a setback involving the AstraZeneca/Oxford coronavirus vaccine, Boris Johnson has said.
The prime minister said he d seen no evidence to suggest any need to delay any planned lifting of coronavirus restrictions.
He was speaking to reporters in Cornwall after the UK s medicines regulator said the AstraZeneca vaccine should only be given to the over-30s, amid concerns it could cause blood clots in younger people.
Following the Medicines and Healthcare products Regulatory Agency (MHRA) ruling, the PM said: These vaccines are safe, they ve saved many thousands of lives and people should come forward to get their jabs and we ll make sure that they get the right jabs.
The syndrome has been reported in people aged from 18 to 79. Of those, 51 were women and 28 were men. There is some evidence the risk of the side effect decreases as people get older.
However, the main reason for drawing a line at age 30 and below relates not to a person s increased risk of the side-effect - it is after all exceedingly rare - it s to do with the balance of risk and benefit of having the vaccine.
Regulators have concluded that above the age of 30, the risk of serious harm or death from Covid is higher than the very small risk of a potentially fatal blood clot.
Below the age of 30, the risk of dying from Covid, if infected, is less than one in 2,500. And of course, the risk is lower still because not everyone gets infected.
Thursday April 8, 2021, 12:20 PM
ITV Science Editor Tom Clarke answers the key questions about the AstraZeneca vaccine. You can watch above or listen to it as a podcast below
Some European countries have restricted the vaccine use in younger people following reports of cerebral venous sinus thrombosis (CVST) – a specific type of clot that prevents blood from draining from the brain, as well as low platelet counts – cells that help blood clot.
Here s what Wednesday s developments mean for the vaccine rollout:
What has been announced?
The Oxford/AstraZeneca vaccine will, for the time being, not be given to anyone under 30 in the UK while experts further investigate potential links between the vaccine and cases of blood clots.